Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct factor Xa inhibitor--after multiple dosing in healthy male subjects - Kubitza, D; Becka, M; Wensing, G; Voith, B; Zuehlsdorf, M (Eur J Clin Pharmacol, 2005)